These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24920796)

  • 1. Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.
    Porta J; Jose J; Roehrig JT; Blair CD; Kuhn RJ; Rossmann MG
    J Virol; 2014 Sep; 88(17):9616-23. PubMed ID: 24920796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.
    Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
    Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
    Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
    Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
    Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission.
    Porta J; Mangala Prasad V; Wang CI; Akahata W; Ng LF; Rossmann MG
    J Virol; 2016 Feb; 90(3):1169-77. PubMed ID: 26537684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.
    Kafai NM; Williamson LE; Binshtein E; Sukupolvi-Petty S; Gardner CL; Liu J; Mackin S; Kim AS; Kose N; Carnahan RH; Jung A; Droit L; Reed DS; Handley SA; Klimstra WB; Crowe JE; Diamond MS
    J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35297953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of murine B-cell epitopes on Eastern equine encephalitis virus glycoprotein E2.
    EnCheng S; Jing Z; Tao Y; QingYuan X; Yongli Q; WenShi W; Peng W; Liang S; Jing S; DongLai W
    Appl Microbiol Biotechnol; 2013 Jul; 97(14):6359-72. PubMed ID: 23512478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3.
    Ma B; Huang C; Ma J; Xiang Y; Zhang X
    Nature; 2021 Oct; 598(7882):677-681. PubMed ID: 34646021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.
    Rülker T; Voß L; Thullier P; O' Brien LM; Pelat T; Perkins SD; Langermann C; Schirrmann T; Dübel S; Marschall HJ; Hust M; Hülseweh B
    PLoS One; 2012; 7(5):e37242. PubMed ID: 22666347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus.
    Zhang R; Hryc CF; Cong Y; Liu X; Jakana J; Gorchakov R; Baker ML; Weaver SC; Chiu W
    EMBO J; 2011 Aug; 30(18):3854-63. PubMed ID: 21829169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor.
    Basore K; Ma H; Kafai NM; Mackin S; Kim AS; Nelson CA; Diamond MS; Fremont DH
    Nature; 2021 Oct; 598(7882):672-676. PubMed ID: 34646020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design.
    Baker WS; Negi S; Braun W; Schein CH
    Antiviral Res; 2020 Oct; 182():104905. PubMed ID: 32800880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.
    Reed DS; Glass PJ; Bakken RR; Barth JF; Lind CM; da Silva L; Hart MK; Rayner J; Alterson K; Custer M; Dudek J; Owens G; Kamrud KI; Parker MD; Smith J
    J Virol; 2014 Oct; 88(20):12077-86. PubMed ID: 25122801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection.
    Parker MD; Buckley MJ; Melanson VR; Glass PJ; Norwood D; Hart MK
    J Virol; 2010 Dec; 84(24):12683-90. PubMed ID: 20926570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.